Dose-Dependent, Therapeutic Potential of Angiotensin-(1–7) for the Treatment of Pulmonary Arterial Hypertension

An Update of the Role of Renin Angiotensin in Cardiovascular Homeostasis

(2015) Ehab Farag et al.   ANESTHESIA AND ANALGESIA

Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation

(2015) G S Magalhães et al.   BRITISH JOURNAL OF PHARMACOLOGY

A novel ACE2 activator reduces monocrotaline-induced pulmonary hypertension by suppressing the JAK/STAT and TGF-β cascades with restored caveolin-1 expression

(2014) Shiori Haga et al.   EXPERIMENTAL LUNG RESEARCH

Chronic Treatment with Ang-(1-7) Reverses Abnormal Reactivity in the Corpus Cavernosum and Normalizes Diabetes-Induced Changes in the Protein Levels of ACE, ACE2, ROCK1, ROCK2 and Omega-Hydroxylase in a Rat Model of Type 1 Diabetes

(2014) Mariam H. M. Yousif et al.   Journal of Diabetes Research

ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis

(2013) AC Simões e Silva et al.   BRITISH JOURNAL OF PHARMACOLOGY

Angiotensin-(1-7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2- and NF-κB-dependent pathways

(2012) Ahmed Z El-Hashim et al.   BRITISH JOURNAL OF PHARMACOLOGY

New therapeutic pathways in the RAS

(2012) Michael Bader et al.   JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM

The Effect of the Thioether-Bridged, Stabilized Angiotensin-(1–7) Analogue Cyclic Ang-(1–7) on Cardiac Remodeling and Endothelial Function in Rats with Myocardial Infarction

(2011) Matej Durik et al.   International Journal of Hypertension

The Angiotensin-Converting Enzyme 2/Angiogenesis-(1–7)/Mas Axis Confers Cardiopulmonary Protection against Lung Fibrosis and Pulmonary Hypertension

(2010) Vinayak Shenoy et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Formation of Plexiform Lesions in Experimental Severe Pulmonary Arterial Hypertension

(2010) Kohtaro Abe et al.   CIRCULATION

Mast cells promote lung vascular remodelling in pulmonary hypertension

(2010) J. Hoffmann et al.   EUROPEAN RESPIRATORY JOURNAL

Oral and pulmonary delivery of thioether-bridged angiotensin-(1–7)

(2010) Louwe de Vries et al.   PEPTIDES

Different Effects of Angiotensin II and Angiotensin-(1-7) on Vascular Smooth Muscle Cell Proliferation and Migration

(2010) Feng Zhang et al.   PLoS One

Evidence for Angiotensin-converting Enzyme 2 as a Therapeutic Target for the Prevention of Pulmonary Hypertension

(2009) Anderson J. Ferreira et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease*

(2009) Ning Yin et al.   CRITICAL CARE MEDICINE

Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation

(2009) T. Thenappan et al.   EUROPEAN RESPIRATORY JOURNAL

Updated Clinical Classification of Pulmonary Hypertension

(2009) Gérald Simonneau et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Ambrisentan for the Treatment of Pulmonary Arterial Hypertension

(2008) Nazzareno Galiè et al.   CIRCULATION

Inhaled milrinone attenuates experimental acute lung injury

(2008) Moritz Bueltmann et al.   INTENSIVE CARE MEDICINE

Angiotensin-(1-7) with Thioether Bridge: An Angiotensin-Converting Enzyme-Resistant, Potent Angiotensin-(1-7) Analog

(2008) L. D. Kluskens et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Therapeutic targets in pulmonary arterial hypertension

(2008) Christopher J. Rhodes et al.   PHARMACOLOGY & THERAPEUTICS